Uk Mhra Gmp
COURTIN & WARNER LIMITEDCOURTIN & WARNER LIMITED – UK MHRA GMP Certificate UK API 24 Insp GMP 24/18490046-0004
Record Details
This Uk Mhra Gmp record concerns COURTIN & WARNER LIMITED, with an inspection on October 1, 2025, issued by the MHRA, covering drugs.
- Company
- COURTIN & WARNER LIMITED
- Compliance status
- GMPC
- Certificate type
- GMP
- Inspection date
- October 1, 2025
- Issued
- January 2, 2026
- MIA number
- UK API 24
- Site address
- UNIT F, MALLING BROOKS, BROOKS ROAD, LEWES, BN7 2QG, UNITED KINGDOM
- Country
- UNITED KINGDOM
- Products
- Human Medicinal Products
- Manufacturing operations
- [4000007414] PHENOBARBITONE SODIUM [1000002667] ETHAMBUTOL [1000009661] NYSTATIN [1000007380] GABAPENTIN [1000008543] LORAZEPAM [2000008271] CAFFEINE CITRATE [1000009411] SUCRALFATE [1000001509] CAFFEINE AND SODIUM BENZOATE Active Substances 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES PHENOBARBITONE SODIUM 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Repacker 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Re-packer 3.5.2 Primary Packaging 3.5.3 Secondary Packaging ETHAMBUTOL 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Re-packer 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Repacking 3.5.2 Primary Packaging 3.5.3 Secondary Packaging NYSTATIN 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Re-packer 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Re-packer 3.5.2 Primary Packaging 3.5.3 Secondary Packaging GABAPENTIN 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Re-packer 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Re-packer 3.5.2 Primary Packaging 3.5.3 Secondary Packaging LORAZEPAM 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Re-packer 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Repacker 3.5.2 Primary Packaging 3.5.3 Secondary Packaging CAFFEINE CITRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1 Manufacture Of Active Substance Intermediates 3.1.2 Manufacture Of Crude Active Substance 3.5 General Finishing Steps 3.5.2 Primary Packaging 3.5.3 Secondary Packaging 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing SUCRALFATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.4 Other Re-packer 3.5 General Finishing Steps 3.5.1 Physical Processing Steps Repacker 3.5.2 Primary Packaging 3.5.3 Secondary Packaging CAFFEINE AND SODIUM BENZOATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1 Manufacture Of Active Substance Intermediates 3.1.2 Manufacture Of Crude Active Substance 3.5 General Finishing Steps 3.5.2 Primary Packaging 3.5.3 Secondary Packaging 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing
- Restrictions
- This certificate is issued based on a desk-based assessment of GMP compliance information provided by the manufacturer. This certificate should be used in combination with the relevant authorisation/registration. A risk-based site inspection programme remains in force.
View Company Profile
ID · 7a79aedf-988a-415f-b569-71cf68bb7b19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.